Brian Goodman, PhD
Brian Goodman is a Co-Founder and Head of Corporate Development and Operations at Aktis Oncology. He is also a Principal at MPM Capital, serves as a member of the Board of Directors at Orna Therapeutics, and is a Board Observer for Triplet Therapeutics. Prior to his time at Aktis, Brian was the Vice President, Head of Business Development at Orna Therapeutics; the Co-Founder and Head of Innovation and Technology at Evelo Biosciences; as well as a Senior Associate with Flagship Pioneering where he worked with the entrepreneurial division to build and launch new biotech ventures. While Brian’s most recent experience has centered on creating, building, and financing early-stage biotech companies, he is a biochemist by training and has worked across a diverse span of science, drug discovery and development including the microbiome, extracellular vesicles, nonviral delivery, RNA medicines, and radiopharmaceuticals. Brian holds a PhD in Biological Chemistry and Molecular Pharmacology from Harvard Medical School. In his free time, Brian enjoys playing soccer and tennis, and is excited to return to his love of travel when safer to do so.